Zhi‐Cheng Jing
Zhi‐Cheng Jing publishes mostly in Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology, on topics such as Pulmonary Hypertension Research and Treatments, Chronic Obstructive Pulmonary Disease (COPD) Research and Venous Thromboembolism Diagnosis and Management.
- World rank
- #308,296 of 7,710,434 ranked researchers
- Rank in China
- #34,187 of 978,568
- Works
- 401
- Citations
- 18k
- Citations per work
- 45.4
What does Zhi‐Cheng Jing research?
Zhi‐Cheng Jing's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences24761.7%
- Medicine24761.7%
- Everything else12831.9%
- Life Sciences266.4%
- 1Pulmonary and Respiratory Medicine33% of their works
- 2Cardiology and Cardiovascular Medicine18% of their works
- 3Molecular Biology6% of their works
- 4Surgery4% of their works
- 5Internal Medicine3% of their works
- 6Epidemiology3% of their works
Research topics
- Pulmonary Hypertension Research and Treatments
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Venous Thromboembolism Diagnosis and Management
- Cardiovascular Issues in Pregnancy
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
- Atrial Fibrillation Management and Outcomes
- Vascular Anomalies and Treatments
Which keywords describe Zhi‐Cheng Jing's research?
The keywords of their largest research topics: Echocardiography, Pulmonary Hypertension, Right Heart Assessment, Diagnosis, Management, Risk Factors, Treatment and Heart Failure.
- Genetics
- Anticoagulant Therapy
- B-Type Natriuretic Peptide
- Chamber Quantification
- Cardiovascular Diseases
- Antithrombotic Therapy
- COPD
- Heart Failure
- Risk Factors
- Diagnosis
- Pulmonary Hypertension
- Echocardiography
- Right Heart Assessment
- Management
- Treatment
- Guidelines
- spirometry
- Venous Thromboembolism
- Pregnancy
- Diastolic Function
- Epidemiology
- Atrial Fibrillation
- Hereditary Hemorrhagic Telangiectasia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Echocardiography2612 topics
- Pulmonary Hypertension2381 topic
- Right Heart Assessment2381 topic
- Diagnosis1034 topics
- Management813 topics
- Risk Factors582 topics
- Treatment502 topics
- Heart Failure432 topics
- Guidelines392 topics
- COPD341 topic
- spirometry341 topic
- Antithrombotic Therapy301 topic
- Venous Thromboembolism301 topic
- Cardiovascular Diseases281 topic
- Pregnancy281 topic
- Chamber Quantification231 topic
- Diastolic Function231 topic
- B-Type Natriuretic Peptide201 topic
- Epidemiology201 topic
- Anticoagulant Therapy191 topic
- Atrial Fibrillation191 topic
- Genetics191 topic
- Hereditary Hemorrhagic Telangiectasia191 topic
Where does Zhi‐Cheng Jing work?
Zhi‐Cheng Jing's main affiliation in the publication record is Chinese Academy of Medical Sciences & Peking Union Medical College, China.
How many publications and citations does Zhi‐Cheng Jing have?
OpenAlex counts 401 works and 18,214 citations for Zhi‐Cheng Jing, an h-index of 52, ranking #308,296 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Zhi‐Cheng Jing. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.